Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: SUNFISH clinical trial | Statement: [FIREFISH, relatedTo, SUNFISH clinical trial]

Target entity: SUNFISH clinical trial
Context triple: [FIREFISH, relatedTo, SUNFISH clinical trial]

• A. APHINITY trial
  The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
• B. EMERGE (Study 302)
  EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
• C. CLEOPATRA trial
  The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
• D. INA trials
  INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
• E. ENSEMBLE trial
  The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: SUNFISH clinical trial
Triple: [FIREFISH, relatedTo, SUNFISH clinical trial]

The SUNFISH clinical trial is a pivotal study evaluating the safety and efficacy of the drug risdiplam in patients with spinal muscular atrophy (SMA).

Target entity: SUNFISH clinical trial
Target entity description: The SUNFISH clinical trial is a pivotal study evaluating the safety and efficacy of the drug risdiplam in patients with spinal muscular atrophy (SMA).

• A. APHINITY trial
  The APHINITY trial is a large phase III clinical study that evaluated the addition of pertuzumab (Perjeta) to standard trastuzumab-based adjuvant therapy in patients with HER2-positive early breast cancer.
• B. EMERGE (Study 302)
  EMERGE (Study 302) is a pivotal Phase 3 clinical trial designed to evaluate the efficacy and safety of the Alzheimer’s disease drug aducanumab (Aduhelm) in patients with early-stage Alzheimer’s.
• C. CLEOPATRA trial
  The CLEOPATRA trial was a pivotal phase III clinical study that demonstrated improved survival by adding pertuzumab (Perjeta) to trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.
• D. INA trials
  INA trials were a series of high-profile court-martials held by the British colonial government in 1945–46 to prosecute officers and soldiers of Subhas Chandra Bose’s Indian National Army, which became a major catalyst for India’s independence movement.
• E. ENSEMBLE trial
  The ENSEMBLE trial was a large, global Phase 3 clinical study designed to evaluate the safety and efficacy of Janssen’s single-dose COVID-19 vaccine in preventing SARS-CoV-2 infection and severe disease.
• F. None of above. chosen